Viveka Roychowdhury

The pharma industry has breached many barriers, but we have miles to go before we can rest on our laurels

It is considerably more difficult to live up to these professed codes of conduct off stage, as it needs to flow right from the…

Suneela Thatte highlighted that while the GCC was initially set up for cost savings in drug development, the focus has shifted to…

Anthony McDonnell, policy fellow at the Center for Global Development's global health policy team and lead author of a recent…

As India positions itself as part of the China+plus one strategy, China has a counter strategy: dumping of low cost imports and…

Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, Viveka…

Putting the patient first, before granting licences seems the solution

Regulatory convergence is extremely important because the basis of all this is science. Science is an objective thing so it…

Mehul Shah, Promoter & Managing Director, Encube Ethicals gives details to Viveka Roychowdhury about the sustainability…

If nutraceuticals shift from FSSAI to CDSCO, they will also come under price control. While this is good for consumers, industry…